These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18278475)

  • 1. Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice.
    Aviello G; Matias I; Capasso R; Petrosino S; Borrelli F; Orlando P; Romano B; Capasso F; Di Marzo V; Izzo AA
    J Mol Med (Berl); 2008 Apr; 86(4):413-22. PubMed ID: 18278475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet.
    Di Marzo V; Capasso R; Matias I; Aviello G; Petrosino S; Borrelli F; Romano B; Orlando P; Capasso F; Izzo AA
    Br J Pharmacol; 2008 Mar; 153(6):1272-80. PubMed ID: 18223666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors.
    Melis M; Pillolla G; Luchicchi A; Muntoni AL; Yasar S; Goldberg SR; Pistis M
    J Neurosci; 2008 Dec; 28(51):13985-94. PubMed ID: 19091987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of endocannabinoids and their analogues in obesity and eating disorders.
    Gaetani S; Kaye WH; Cuomo V; Piomelli D
    Eat Weight Disord; 2008 Sep; 13(3):e42-8. PubMed ID: 19011363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance.
    Borrelli F; Izzo AA
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):33-49. PubMed ID: 19285259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
    Ho WS; Barrett DA; Randall MD
    Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice.
    Cluny NL; Keenan CM; Lutz B; Piomelli D; Sharkey KA
    Neurogastroenterol Motil; 2009 Apr; 21(4):420-9. PubMed ID: 19140957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.
    Fu J; Oveisi F; Gaetani S; Lin E; Piomelli D
    Neuropharmacology; 2005 Jun; 48(8):1147-53. PubMed ID: 15910890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine.
    Fu J; Astarita G; Gaetani S; Kim J; Cravatt BF; Mackie K; Piomelli D
    J Biol Chem; 2007 Jan; 282(2):1518-28. PubMed ID: 17121838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).
    Guzmán M; Lo Verme J; Fu J; Oveisi F; Blázquez C; Piomelli D
    J Biol Chem; 2004 Jul; 279(27):27849-54. PubMed ID: 15123613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties.
    Astarita G; Di Giacomo B; Gaetani S; Oveisi F; Compton TR; Rivara S; Tarzia G; Mor M; Piomelli D
    J Pharmacol Exp Ther; 2006 Aug; 318(2):563-70. PubMed ID: 16702440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis.
    Montecucco F; Matias I; Lenglet S; Petrosino S; Burger F; Pelli G; Braunersreuther V; Mach F; Steffens S; Di Marzo V
    Atherosclerosis; 2009 Aug; 205(2):433-41. PubMed ID: 19187936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide.
    Azari EK; Ramachandran D; Weibel S; Arnold M; Romano A; Gaetani S; Langhans W; Mansouri A
    Am J Physiol Regul Integr Comp Physiol; 2014 Jul; 307(2):R167-78. PubMed ID: 24829501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oleoylethanolamide and Palmitoylethanolamide Enhance IFNβ-Induced Apoptosis in Human Neuroblastoma SH-SY5Y Cells.
    Camoglio C; Balla J; Fadda P; Dedoni S
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis.
    Sanchez AM; Cioffi R; Viganò P; Candiani M; Verde R; Piscitelli F; Di Marzo V; Garavaglia E; Panina-Bordignon P
    Reprod Sci; 2016 Aug; 23(8):1071-9. PubMed ID: 26887427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide.
    Romano A; Karimian Azari E; Tempesta B; Mansouri A; Micioni Di Bonaventura MV; Ramachandran D; Lutz TA; Bedse G; Langhans W; Gaetani S
    Physiol Behav; 2014 Sep; 136():55-62. PubMed ID: 24802360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide.
    Cani PD; Montoya ML; Neyrinck AM; Delzenne NM; Lambert DM
    Br J Nutr; 2004 Nov; 92(5):757-61. PubMed ID: 15533263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide.
    Gaetani S; Oveisi F; Piomelli D
    Neuropsychopharmacology; 2003 Jul; 28(7):1311-6. PubMed ID: 12700681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats.
    Murillo-Rodríguez E; Palomero-Rivero M; Millán-Aldaco D; Arias-Carrión O; Drucker-Colín R
    PLoS One; 2011; 6(7):e20766. PubMed ID: 21779318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα.
    Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
    FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.